Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Amanda H. Laabs currently holds 23,899 shares of Medline Inc. (MDLN), valued at approximately $0. This represents their equity stake as Chief Product Officer.
Based on SEC Form 4 filings, Amanda H. Laabs has been a net neutral trader of MDLN stock. They have purchased $0 and sold $0 worth of shares.
Amanda H. Laabs's most recent insider trade was on Jun 15, 2026, when they sold 1,889 shares at $36.61 per share.
Amanda H. Laabs serves as Chief Product Officer at Medline Inc. (MDLN). They have executed 1 insider transactions totaling $0 over their tenure at the company.
Amanda H. Laabs holds the position of Chief Product Officer at Medline Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Amanda H. Laabs has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Amanda H. Laabs was on Jun 15, 2026, when they sold $69.2K worth of MDLN shares. This transaction involved 1,889 shares at $36.61 per share.
Amanda H. Laabs currently owns 23,899 shares of Medline Inc. (MDLN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Amanda H. Laabs's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Amanda H. Laabs has 1 Form 4 filings on record as an insider at Medline Inc..
Set alerts for Amanda H. Laabs and 40,000+ other insiders.